| Analyst | Bewertung | Kursziel | Kurs | Abstand | Datum |
|---|---|---|---|---|---|
| Berenberg | 3.901 € | 3.365,35 € | 536,131 € | 05.02.26 | |
| DZ | 3.545 € | 3.364,97 € | 180,46 € | 04.02.26 | |
| UBS | 3.395 € | 3.263,08 € | 132,421 € | 30.01.26 | |
| Barclays | 3.984 € | 3.263,08 € | 720,898 € | 30.01.26 | |
| Jefferies | 3.820 € | 3.263,08 € | 557,173 € | 30.01.26 | |
| JPMorgan | 3.929 € | 3.263,08 € | 666,323 € | 30.01.26 | |
| Deutsche Bank | 4.188 € | 3.584,3 € | 603,521 € | 24.11.25 | |
| Goldman | 4.420 € | 3.703,38 € | 716,826 € | 11.11.25 | |
| DZ Bank | 3.893 € | 3.615,05 € | 277,677 € | 01.09.25 |
| Name | Positiv | Neutral | Negativ | Ø Kursziel | Kurs | Abstand |
|---|---|---|---|---|---|---|
| Givaudan SA | 5 | 4 | 0 | 3.897,42 € | 3.311,82 € | 585,60 € |
| DSM-Firmenich AG | 1 | - | - | 96,00 € | 60,62 € | 35,38 € |